Pyxis Oncology, Inc.Pyxis Oncology, Inc.Pyxis Oncology, Inc.

Pyxis Oncology, Inc.

No trades
See on Supercharts
Market capitalization
‪241.83 M‬USD
−1.86USD
‪−73.79 M‬USD
‪46.27 M‬
Beta (1Y)
1.91

About Pyxis Oncology, Inc.

CEO
Lara S. Sullivan
Headquarters
Boston
Employees (FY)
50
Founded
2018
ISIN
US7473241013
FIGI
BBG00PQFFCV5
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. The company was founded by David Steinberg, Shaan C. Gandhi, and John L. Flavin on June 11, 2018 and is headquartered in Boston, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PYXS is 4.16 USD — it has decreased by 8.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pyxis Oncology, Inc. stocks are traded under the ticker PYXS.
Pyxis Oncology, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
PYXS stock is 11.58% volatile and has beta coefficient of 1.91. Check out the list of the most volatile stocks — is Pyxis Oncology, Inc. there?
One year price forecast for Pyxis Oncology, Inc. has a max estimate of 12.00 USD and a min estimate of 5.00 USD.
PYXS earnings for the last quarter are −0.56 USD per share, whereas the estimation was −0.51 USD resulting in a −10.48% surprise. The estimated earnings for the next quarter are −0.47 USD per share. See more details about Pyxis Oncology, Inc. earnings.
Pyxis Oncology, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪200.00 K‬ USD.
Yes, you can track Pyxis Oncology, Inc. financials in yearly and quarterly reports right on TradingView.
PYXS stock has fallen by 21.36% compared to the previous week, the month change is a 19.07% fall, over the last year Pyxis Oncology, Inc. has showed a 29.60% increase.
PYXS net income for the last quarter is ‪−15.60 M‬ USD, while the quarter before that showed ‪−23.05 M‬ USD of net income which accounts for 32.33% change. Track more Pyxis Oncology, Inc. financial stats to get the full picture.
Today Pyxis Oncology, Inc. has the market capitalization of ‪241.84 M‬, it has increased by 3.72% over the last week.
No, PYXS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PYXS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pyxis Oncology, Inc. stock right from TradingView charts — choose your broker and connect to your account.
PYXS reached its all-time high on Oct 8, 2021 with the price of 19.00 USD, and its all-time low was 1.10 USD and was reached on Dec 15, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 50.00 employees. See our rating of the largest employees — is Pyxis Oncology, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pyxis Oncology, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pyxis Oncology, Inc. stock shows the buy signal. See more of Pyxis Oncology, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Pyxis Oncology, Inc. future price: according to them, PYXS price has a max estimate of 12.00 USD and a min estimate of 5.00 USD. Read a more detailed Pyxis Oncology, Inc. forecast: see what analysts think of Pyxis Oncology, Inc. and suggest that you do with its stocks.